United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $927,578,904.60
- Sept. 24, 2025
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 26, 2016 | CEO | 5,547 | $117.57 | Sell | $652,160.79 | |
| May 19, 2016 | CEO | 5,546 | $110.75 | Sell | $614,219.50 | |
| May 12, 2016 | Director | 3,000 | $110.00 | Sell | $330,000.00 | |
| May 12, 2016 | CEO | 5,547 | $109.02 | Sell | $604,733.94 | |
| May 5, 2016 | CEO | 5,546 | $107.79 | Sell | $597,803.34 | |
| April 28, 2016 | CEO | 5,547 | $106.81 | Sell | $592,475.07 | |
| April 21, 2016 | CEO | 5,546 | $115.74 | Sell | $641,894.04 | |
| April 14, 2016 | CEO | 5,547 | $114.32 | Sell | $634,133.04 | |
| April 7, 2016 | CEO | 5,546 | $113.31 | Sell | $628,417.26 | |
| March 24, 2016 | CEO | 5,546 | $110.80 | Sell | $614,496.80 | |
| March 17, 2016 | CEO | 5,547 | $118.22 | Sell | $655,766.34 | |
| March 10, 2016 | CEO | 5,546 | $123.41 | Sell | $684,431.86 | |
| March 3, 2016 | CEO | 5,547 | $126.78 | Sell | $703,248.66 | |
| Feb. 25, 2016 | CEO | 5,546 | $122.45 | Sell | $679,107.70 | |
| Feb. 18, 2016 | CEO | 5,547 | $128.26 | Sell | $711,458.22 | |
| Feb. 11, 2016 | CEO | 5,546 | $120.47 | Sell | $668,126.62 | |
| Feb. 4, 2016 | Director | 3,000 | $122.66 | Sell | $367,980.00 | |
| Feb. 4, 2016 | CEO | 5,547 | $122.13 | Sell | $677,455.11 | |
| Jan. 28, 2016 | CEO | 5,546 | $124.00 | Sell | $687,704.00 | |
| Jan. 21, 2016 | CEO | 5,547 | $127.00 | Sell | $704,469.00 | |
| Jan. 14, 2016 | CEO | 5,546 | $135.94 | Sell | $753,923.24 | |
| Jan. 7, 2016 | Director | 3,000 | $143.75 | Sell | $431,250.00 | |
| Jan. 7, 2016 | CEO | 5,547 | $145.84 | Sell | $808,974.48 | |
| Dec. 24, 2015 | CEO | 5,546 | $159.58 | Sell | $885,030.68 | |
| Dec. 17, 2015 | CEO | 5,546 | $158.49 | Sell | $878,985.54 | |
| Dec. 10, 2015 | CEO | 5,546 | $154.49 | Sell | $856,801.54 | |
| Dec. 3, 2015 | CEO | 5,546 | $154.49 | Sell | $856,801.54 | |
| Dec. 3, 2015 | Director | 3,000 | $157.22 | Sell | $471,660.00 | |
| Nov. 27, 2015 | CEO | 5,561 | $153.81 | Sell | $855,337.41 | |
| Nov. 19, 2015 | CEO | 9,661 | $148.56 | Sell | $1,435,238.16 | |
| Nov. 12, 2015 | CEO | 4,115 | $147.72 | Sell | $607,867.80 | |
| Nov. 5, 2015 | CEO | 4,115 | $149.16 | Sell | $613,793.40 | |
| Nov. 5, 2015 | Director | 3,000 | $149.63 | Sell | $448,890.00 | |
| Nov. 3, 2015 | Director | 7,500 | $153.22 | Sell | $1,149,150.00 | |
| Oct. 29, 2015 | CEO | 9,662 | $141.89 | Sell | $1,370,941.18 | |
| Oct. 28, 2015 | CEO | 2,211 | $136.58 | Sell | $301,978.38 | |
| Oct. 26, 2015 | CEO | 2,592 | $127.13 | Sell | $329,520.96 | |
| Oct. 22, 2015 | CEO | 9,662 | $122.40 | Sell | $1,182,628.80 | |
| Oct. 21, 2015 | CEO | 2,211 | $123.63 | Sell | $273,345.93 | |
| Oct. 19, 2015 | CEO | 2,592 | $126.71 | Sell | $328,432.32 | |
| Oct. 15, 2015 | CEO | 9,662 | $126.22 | Sell | $1,219,537.64 | |
| Oct. 14, 2015 | CEO | 2,211 | $123.53 | Sell | $273,124.83 | |
| Oct. 12, 2015 | CEO | 2,592 | $123.51 | Sell | $320,137.92 | |
| Oct. 8, 2015 | CEO | 9,662 | $122.48 | Sell | $1,183,401.76 | |
| Oct. 7, 2015 | CEO | 2,211 | $120.88 | Sell | $267,265.68 | |
| Oct. 5, 2015 | CEO | 2,592 | $126.88 | Sell | $328,872.96 | |
| Oct. 1, 2015 | CEO | 6,326 | $131.11 | Sell | $829,401.86 | |
| Oct. 1, 2015 | Director | 3,000 | $131.32 | Sell | $393,960.00 | |
| Oct. 1, 2015 | EVP | 6,000 | $129.38 | Sell | $776,280.00 | |
| Sept. 29, 2015 | Director | 5,000 | $139.19 | Sell | $695,950.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Michael Benkowitz, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, James Edgemond, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Paul A. Mahon, Ray Kurzweil, DWEK RAYMOND, Tommy G. Thompson, Jan Malcolm, MAHON PAUL A, Louis Sullivan, Judy D. Olian, and R Paul Gray
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 393 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $386,981,200.91.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Sept. 24, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.
